These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 14738225

  • 1. Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer.
    Gessner C, Woischwill C, Schumacher A, Liebers U, Kuhn H, Stiehl P, Jürchott K, Royer HD, Witt C, Wolff G.
    Eur Respir J; 2004 Jan; 23(1):14-9. PubMed ID: 14738225
    [Abstract] [Full Text] [Related]

  • 2. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
    Shibahara K, Sugio K, Osaki T, Uchiumi T, Maehara Y, Kohno K, Yasumoto K, Sugimachi K, Kuwano M.
    Clin Cancer Res; 2001 Oct; 7(10):3151-5. PubMed ID: 11595709
    [Abstract] [Full Text] [Related]

  • 3. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T, Uramoto H, Oyama T, Yashima Y, Gu C, Morita M, Sugio K, Kohno K, Yasumoto K.
    Anticancer Res; 2005 Oct; 25(5):3437-43. PubMed ID: 16101161
    [Abstract] [Full Text] [Related]

  • 4. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M, Azuma K, Kawahara A, Basaki Y, Hattori S, Yanagawa T, Terazaki Y, Takamori S, Shirouzu K, Aizawa H, Nakano K, Kage M, Kuwano M, Ono M.
    J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
    [Abstract] [Full Text] [Related]

  • 5. BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer.
    Gessner C, Liebers U, Kuhn H, Stiehl P, Witt C, Schauer J, Wolff G.
    Eur Respir J; 2002 Jan; 19(1):134-40. PubMed ID: 11843312
    [Abstract] [Full Text] [Related]

  • 6. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
    Gu C, Oyama T, Osaki T, Kohno K, Yasumoto K.
    Anticancer Res; 2001 Jan; 21(4A):2357-62. PubMed ID: 11724293
    [Abstract] [Full Text] [Related]

  • 7. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?
    Kamura T, Yahata H, Amada S, Ogawa S, Sonoda T, Kobayashi H, Mitsumoto M, Kohno K, Kuwano M, Nakano H.
    Cancer; 1999 Jun 01; 85(11):2450-4. PubMed ID: 10357417
    [Abstract] [Full Text] [Related]

  • 8. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
    Oda Y, Ohishi Y, Saito T, Hinoshita E, Uchiumi T, Kinukawa N, Iwamoto Y, Kohno K, Kuwano M, Tsuneyoshi M.
    J Pathol; 2003 Feb 01; 199(2):251-8. PubMed ID: 12533839
    [Abstract] [Full Text] [Related]

  • 9. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
    Hyogotani A, Ito K, Yoshida K, Izumi H, Kohno K, Amano J.
    Clin Lung Cancer; 2012 Sep 01; 13(5):375-84. PubMed ID: 22284440
    [Abstract] [Full Text] [Related]

  • 10. Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.
    Janz M, Harbeck N, Dettmar P, Berger U, Schmidt A, Jürchott K, Schmitt M, Royer HD.
    Int J Cancer; 2002 Jan 20; 97(3):278-82. PubMed ID: 11774277
    [Abstract] [Full Text] [Related]

  • 11. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
    Oda Y, Sakamoto A, Shinohara N, Ohga T, Uchiumi T, Kohno K, Tsuneyoshi M, Kuwano M, Iwamoto Y.
    Clin Cancer Res; 1998 Sep 20; 4(9):2273-7. PubMed ID: 9748149
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
    Korkolopoulou P, Oates J, Crocker J, Edwards C.
    J Clin Pathol; 1993 Dec 20; 46(12):1093-6. PubMed ID: 7904273
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression.
    Okamoto T, Izumi H, Imamura T, Takano H, Ise T, Uchiumi T, Kuwano M, Kohno K.
    Oncogene; 2000 Dec 14; 19(54):6194-202. PubMed ID: 11175333
    [Abstract] [Full Text] [Related]

  • 17. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
    Skov BG, Fischer BM, Pappot H.
    Lung Cancer; 2008 Jan 14; 59(1):88-94. PubMed ID: 17905466
    [Abstract] [Full Text] [Related]

  • 18. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
    Yahata H, Kobayashi H, Kamura T, Amada S, Hirakawa T, Kohno K, Kuwano M, Nakano H.
    J Cancer Res Clin Oncol; 2002 Nov 14; 128(11):621-6. PubMed ID: 12458343
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.
    Bader AG, Vogt PK.
    Mol Cell Biol; 2005 Mar 14; 25(6):2095-106. PubMed ID: 15743808
    [Abstract] [Full Text] [Related]

  • 20. p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival.
    Mitsudomi T, Oyama T, Nishida K, Ogami A, Osaki T, Nakanishi R, Sugio K, Yasumoto K, Sugimachi K.
    Ann Oncol; 1995 Mar 14; 6 Suppl 3():S9-13. PubMed ID: 8616120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.